BRANDON PRICE

Profile

First Name

: BRANDON

Middle Name

:

Last Name

: PRICE

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

NASCENT BIOTECH INC.

SEAN CARRICK, MARK GLASSY, LOWELL HOLDEN

DIRECTOR

PRAIRIE PLANT SYSTEMS INC.

DOUG BANSET, DON CHING, ROB DUGUID, THOMAS GORMAN, MARIANNE GREER, RICK HOYT, JOHN KNOWLES, DWAYNE LASHYN, BRUCE MACKLER, BRENT ZETTL

DIRECTOR

CANNIMED THERAPEUTICS INC.

GULWANT BAJWA, DOUG BANZET, DONALD CHING, ROB DUGUID, MARIANNE GREER, LARRY HOLBROOK, RICHARD HOYT, JOHN KNOWLES, DWAYNE LASHYN, BRUCE MACKLER, BRENTON ZETTL

EXECUTIVE OFFICER, DIRECTOR, PROMOTER

ETHICANN PHARMACEUTICALS INC.

ROBERT AURITT, ULRICH ELBEN, RICHARD HOYT, DWAYNE LASHYN, BRUCE MACKLER, BRUCE F MACKLER, NEIL MARUOKA, JAMES W WISHART

DIRECTOR

GOODWIN BIOTECHNOLOGY, INC

SUNIL K. AGARWAL, SOOYOUNG S. LEE, JERRY LIAO, CESAR MENEZES, DIVYA MENEZES, MARIA EMILA MENEZES, KENT PAYNE, KARL PINTO, NIKHIL PURI, DARRIN SCHELLIN, STEVEN VORGITY

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2025-12-05

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2024-11-01

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2023-09-12

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2022-04-22

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2019-02-04

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2019-02-04

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2019-02-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-12-29

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2016-07-15

D

BIOTECHNOLOGY

NO REVENUES

Equity

2014-03-13